165 related articles for article (PubMed ID: 10540156)
1. Qualitative and quantitative studies of autoantibodies to phospholipids in diabetes mellitus.
Gargiulo P; Goldberg J; Romani B; Schiaffini R; Ciampalini P; Faulk WP; McIntyre JA
Clin Exp Immunol; 1999 Oct; 118(1):30-4. PubMed ID: 10540156
[TBL] [Abstract][Full Text] [Related]
2. Increased incidence of antiphospholipid antibodies in left ventricular assist system recipients.
Fastenau DR; Wagenknecht DR; McIntyre JA
Ann Thorac Surg; 1999 Jul; 68(1):137-42. PubMed ID: 10421129
[TBL] [Abstract][Full Text] [Related]
3. Patterns of anti-phospholipid antibody specificities.
Gilman-Sachs A; Lubinski J; Beer AE; Brend S; Beaman KD
J Clin Lab Immunol; 1991 Jun; 35(2):83-8. PubMed ID: 1668762
[TBL] [Abstract][Full Text] [Related]
4. Phospholipid antibodies in alcoholic liver disease.
Chedid A; Chadalawada KR; Morgan TR; Moritz TE; Mendenhall CL; Hammond JB; Emblad PW; Cifuentes DC; Kwak JW; Gilman-Sachs A
Hepatology; 1994 Dec; 20(6):1465-71. PubMed ID: 7982646
[TBL] [Abstract][Full Text] [Related]
5. Frequency and specificities of antiphospholipid antibodies (aPL) in volunteer blood donors.
McIntyre JA; Wagenknech DR; Waxman DW
Immunobiology; 2003; 207(1):59-63. PubMed ID: 12638905
[TBL] [Abstract][Full Text] [Related]
6. Detection of anti-phospholipid (cardiolipin, phosphatidylserine) antibodies in the serum of patients with non insulin-dependent (type 2) diabetes mellitus and macroangiopathy. Coexistence of anti-platelet reactivity.
Triolo G; Giardina E; Scarantino G; Seddio G; Bompiani G
Diabetes Res; 1989 Feb; 10(2):63-7. PubMed ID: 2743710
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and heterogeneity of antiphosphatidylethanolamine antibodies in patients with recurrent early pregnancy losses.
Sugi T; Katsunuma J; Izumi S; McIntyre JA; Makino T
Fertil Steril; 1999 Jun; 71(6):1060-5. PubMed ID: 10360910
[TBL] [Abstract][Full Text] [Related]
8. Antiphospholipid antibodies in heart transplant recipients.
McIntyre JA; Wagenknecht DR; Faulk WP
Clin Cardiol; 1995 Oct; 18(10):575-80. PubMed ID: 8785903
[TBL] [Abstract][Full Text] [Related]
9. Anticardiolipin antibodies: isotype distribution and phospholipid specificity.
Gharavi AE; Harris EN; Asherson RA; Hughes GR
Ann Rheum Dis; 1987 Jan; 46(1):1-6. PubMed ID: 3813670
[TBL] [Abstract][Full Text] [Related]
10. The outcome of ELISA for antiphosphatidylethanolamine antibodies is dependent on the composition of phosphatidylethanolamine.
Hou S; Harper PE; Bardin N; Zhao M
J Immunol Methods; 2017 Jan; 440():27-34. PubMed ID: 27784626
[TBL] [Abstract][Full Text] [Related]
11. Elevated Levels of Plasma IgA Autoantibodies against Oxidized LDL Found in Proliferative Diabetic Retinopathy but Not in Nonproliferative Retinopathy.
Vavuli S; Salonurmi T; Loukovaara S; Nissinen AE; Savolainen MJ; Liinamaa MJ
J Diabetes Res; 2016; 2016():2614153. PubMed ID: 28090539
[No Abstract] [Full Text] [Related]
12. Incidence of antiphospholipid antibodies in patients with monoclonal gammopathy of undetermined significance.
Stern JJ; Ng RH; Triplett DA; McIntyre JA
Am J Clin Pathol; 1994 Apr; 101(4):471-4. PubMed ID: 8160639
[TBL] [Abstract][Full Text] [Related]
13. Advantage of using both anionic and zwitterionic phospholipid antigens for the detection of antiphospholipid antibodies.
Laroche P; Berard M; Rouquette AM; Desgruelle C; Boffa MC
Am J Clin Pathol; 1996 Oct; 106(4):549-54. PubMed ID: 8853046
[TBL] [Abstract][Full Text] [Related]
14. Phospholipid and glutamic acid decarboxylase autoantibodies in diabetic neuropathy.
Vinik AI; Leichter SB; Pittenger GL; Stansberry KB; Holland MT; Powers AC; Suwanwalaikorn S
Diabetes Care; 1995 Sep; 18(9):1225-32. PubMed ID: 8612435
[TBL] [Abstract][Full Text] [Related]
15. Different anticoagulant and immunological properties of anti-prothrombin antibodies in patients with antiphospholipid antibodies.
Galli M; Beretta G; Daldossi M; Bevers EM; Barbui T
Thromb Haemost; 1997 Mar; 77(3):486-91. PubMed ID: 9065999
[TBL] [Abstract][Full Text] [Related]
16. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome.
Safa O; Crippa L; Della Valle P; Sabbadini MG; Viganò D'Angelo S; D'Angelo A
Haematologica; 1999 Sep; 84(9):829-38. PubMed ID: 10477458
[TBL] [Abstract][Full Text] [Related]
17. High titer of anti-phosphatidylserine-prothrombin complex antibodies in patients with cutaneous polyarteritis nodosa.
Kawakami T; Yamazaki M; Mizoguchi M; Soma Y
Arthritis Rheum; 2007 Dec; 57(8):1507-13. PubMed ID: 18050170
[TBL] [Abstract][Full Text] [Related]
18. Isotype distribution and clinical significance of antibodies to cardiolipin, phosphatidic acid, phosphatidylinositol and phosphatidylserine in systemic lupus erythematosus: prospective analysis of a series of 92 patients.
López-Soto A; Cervera R; Font J; Bové A; Reverter JC; Muñoz FJ; Miret C; Espinosa G; Ordinas A; Ingelmo M
Clin Exp Rheumatol; 1997; 15(2):143-9. PubMed ID: 9196865
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of antiphospholipid antibodies is not different in Chilean diabetic patients and normal individuals.
Palomo IG; Mujica VE; Alarcón ML; Pereira JG; Vásquez MR
J Diabetes Complications; 2005; 19(3):133-7. PubMed ID: 15866057
[TBL] [Abstract][Full Text] [Related]
20. Anti-phospholipid antibodies in diabetes mellitus.
Gin H; Vergnot V; Diakou V; Perret AM; Poix J; Cassagne C; Maneta-Peyret L
Clin Chem Lab Med; 2002 Jun; 40(6):604-8. PubMed ID: 12211656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
